BBLG Q2 2023 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$2M

EPS (Diluted)

$-5.21

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$16,670

Balance Sheet

Total Assets

$8M

Total Liabilities

$2M

Stockholders' Equity

$6M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$469,304	-547.8%
Net Income	-$2M	-$469,304	-276.9%